ClinConnect ClinConnect Logo
Search / Trial NCT06179641

Comparison of Two Different Regional Analgesia Techniques for Patients Undergoing Total Knee Arthroplasty

Launched by CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS · Dec 11, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Nerve Block Pain Management Postoperative Pain

ClinConnect Summary

This clinical trial is studying two different methods of pain relief for patients undergoing total knee replacement surgery. The goal is to find out which technique, called IPACK or selective tibial nerve block, works better to reduce pain after the surgery. Both methods will be used alongside a spinal block to help manage pain during and after the operation. Researchers will compare how much pain patients feel and how much morphine they need to take after the surgery.

To participate in this trial, you need to be at least 18 years old and scheduled for a total knee replacement surgery. You should be in good overall health, as indicated by specific classifications, and be able to give informed consent to join the study. If you have certain allergies, are on specific medications, or have certain health conditions, you may not be eligible. If you join the trial, you will receive one of the two pain relief techniques, and your recovery will be monitored to help determine which method is more effective.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • American Society of Anesthesiologists classification I-III
  • 18 yo or older
  • patients scheduled for total knee arthroplasty under central spinal anesthesia
  • informed consent signed
  • Exclusion Criteria:
  • Refusal or inability for informed consent
  • Known allergies to ropivacaine, acetaminophen, ibuprofen, ketorolac, morphine, ondansetron or dexamethasone
  • Secondary surgical revision
  • Opioid treatment such as morphine, hydrocodone, hydromorphone, tramadol, methadone, fentanyl, buprenorphine or codeine
  • Bleeding diathesis
  • Neurological deficit
  • Known renal insufficiency (eGFR \<45 ml/min)
  • Known hepatic insufficiency (Child score B or C)
  • Alcohol abuse

About Centre Hospitalier Universitaire Vaudois

The Centre Hospitalier Universitaire Vaudois (CHUV) is a leading academic medical center located in Lausanne, Switzerland, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, CHUV plays a pivotal role in translating scientific discoveries into transformative therapies, enhancing patient care across a diverse range of medical disciplines. With a multidisciplinary team of experts and state-of-the-art facilities, CHUV is dedicated to fostering collaboration and delivering high-quality evidence that informs clinical practice and policy.

Locations

Lausanne, Vaud, Switzerland

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported